MedTrace Logo

BM Collection From NICU Infants for Composition

NCT02570698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-08-18

No results posted yet for this study

Summary

The primary objective of this study is to collect feces from premature infants over a five weeks period to characterize its composition. Metabolomics, Proteomics, Genomics and Microbiome analyses and cell-based assays will be performed to identify individual components present in feces, which may contribute to the onset of irritation in the diapered area of premature infants.

Conditions

  • Diaper Dermatitis

Sponsors & Collaborators

  • Kimberly-Clark Corporation

    lead INDUSTRY

Principal Investigators

  • Lawrence Eichenfield, MD · UCSD Rady Children's Hospital

Eligibility

Max Age
30 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-12-07
Completion
2017-01-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02570698 on ClinicalTrials.gov